首页 > 最新文献

Pakistan Journal of Medical Sciences最新文献

英文 中文
Chemotherapy combined with Shenmai injection alleviates inflammatory response and side effects in the patients with advanced colorectal cancer: A retrospective analysis. 化疗联合神麦注射液可减轻晚期结直肠癌患者的炎症反应和副作用:回顾性分析
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9881
Yude Jin, Wei Zhu, Hanbin Dai, Xiaowei He

Objective: To assess the inflammatory response and side effects of chemotherapy combined with Shenmai injection (SMI) in the treatment of patients with advanced colorectal cancer (CRC).

Methods: This retrospective cohort study included the clinical data of 152 patients with advanced CRC admitted to the First Affiliated Hospital of Huzhou University from April 2020 to April 2023. The patients were divided into control group (patients received chemotherapy treatment, n=75) and observation group (patients received chemotherapy combined with SMI, n=77) based on the treatment received. Tumor control rate, levels of immune function indicators before and after treatment, levels of inflammatory factor indicators, and incidence of toxic side effects in two groups were analyzed.

Results: Tumor control rate in the observation group (89.61%) was higher than that in the control group (77.33%) (P<0.05). After the treatment, the levels of CD3+, CD4+, CD4+/CD8+in both groups were significantly higher than before the treatment, and significantly higher in the observation group compared to the control group (P<0.05). After the treatment, serum levels of interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-8 (IL-8) in both groups decreased compared to pretreatment levels, and was significantly lower in the observation group (P<0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P<0.05).

Conclusions: Compared with chemotherapy alone, chemotherapy combined with SMI better alleviates inflammatory response in patients with advanced CRC, enhance immune function, and improve tumor control rate, with a lower incidence of toxic side effects.

目的:评估化疗联合神麻注射液治疗晚期结直肠癌患者的炎症反应和副作用:评估化疗联合神麻注射液(SMI)治疗晚期结直肠癌(CRC)患者的炎症反应和副作用:这项回顾性队列研究纳入了湖州大学第一附属医院2020年4月至2023年4月收治的152例晚期CRC患者的临床数据。根据患者接受治疗的不同分为对照组(接受化疗的患者,75 例)和观察组(接受化疗联合 SMI 的患者,77 例)。分析两组患者的肿瘤控制率、治疗前后的免疫功能指标水平、炎症因子指标水平以及毒副反应发生率:结果:观察组的肿瘤控制率(89.61%)高于对照组(77.33%)(两组的P+、CD4+、CD4+/CD8+均明显高于治疗前,且观察组明显高于对照组(PPP结论:与单纯化疗相比,化疗联合放疗的疗效更佳:与单纯化疗相比,化疗联合SMI能更好地缓解晚期CRC患者的炎症反应,增强免疫功能,提高肿瘤控制率,且毒副作用发生率较低。
{"title":"Chemotherapy combined with Shenmai injection alleviates inflammatory response and side effects in the patients with advanced colorectal cancer: A retrospective analysis.","authors":"Yude Jin, Wei Zhu, Hanbin Dai, Xiaowei He","doi":"10.12669/pjms.40.9.9881","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9881","url":null,"abstract":"<p><strong>Objective: </strong>To assess the inflammatory response and side effects of chemotherapy combined with Shenmai injection (SMI) in the treatment of patients with advanced colorectal cancer (CRC).</p><p><strong>Methods: </strong>This retrospective cohort study included the clinical data of 152 patients with advanced CRC admitted to the First Affiliated Hospital of Huzhou University from April 2020 to April 2023. The patients were divided into control group (patients received chemotherapy treatment, n=75) and observation group (patients received chemotherapy combined with SMI, n=77) based on the treatment received. Tumor control rate, levels of immune function indicators before and after treatment, levels of inflammatory factor indicators, and incidence of toxic side effects in two groups were analyzed.</p><p><strong>Results: </strong>Tumor control rate in the observation group (89.61%) was higher than that in the control group (77.33%) (<i>P</i><0.05). After the treatment, the levels of CD3<sup>+</sup>, CD4<sup>+</sup>, CD4<sup>+</sup>/CD8<sup>+</sup>in both groups were significantly higher than before the treatment, and significantly higher in the observation group compared to the control group (<i>P</i><0.05). After the treatment, serum levels of interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-8 (IL-8) in both groups decreased compared to pretreatment levels, and was significantly lower in the observation group (<i>P</i><0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (<i>P</i><0.05).</p><p><strong>Conclusions: </strong>Compared with chemotherapy alone, chemotherapy combined with SMI better alleviates inflammatory response in patients with advanced CRC, enhance immune function, and improve tumor control rate, with a lower incidence of toxic side effects.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"1953-1957"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical effect of psychological nursing and nutritional intervention in radiopharmaceutical therapy of patients with thyroid carcinoma. 心理护理和营养干预在甲状腺癌患者放射性药物治疗中的临床效果。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9020
Jing Chen, Yuanzheng Liu

Objective: To investigate the clinical value of psychological nursing and nutritional intervention in radiopharmaceutical therapy of patients with thyroid carcinoma.

Methods: This was retrospective study. One hundred and twenty patients with thyroid carcinoma were included at Baoding No.1 Central Hospital from May 10, 2021 to July 10, 2023 to as subjects and randomly divided into the control group and the experimental group (n=60 each group). Patients in the control group were given conventional nursing, while those in the experimental group received psychological nursing and nutritional intervention. The differences in quality of life, compliance, satisfaction and cognitive level between the two groups before and after intervention were compared.

Results: After intervention, the scores of emotional functions, role function, cognitive function, physical function and social function of the experimental group were significantly higher than those of the control group, with statistically significant differences (P= 0.00); The compliance of the experimental group was 100%, which was significantly higher than 90% of the control group, with a statistically significant difference (P= 0.01). Moreover, the scores of SAS and SDS in the experimental group were significantly lower than those in the control group after intervention, with a statistically significant difference (P= 0.00).

Conclusion: Psychological nursing and nutritional intervention may result in a variety of benefits for patients with thyroid carcinoma receiving radiopharmaceutical therapy, such as effectively ameliorating the quality of life of patients, improving the cognitive level of patients with the disease and treatment compliance, reducing anxiety and depression, and enhancing patient satisfaction with nursing.

目的:探讨心理护理和营养干预在甲状腺癌放射性药物治疗中的临床价值:探讨心理护理和营养干预在甲状腺癌患者放射性药物治疗中的临床价值:本研究为回顾性研究。选取2021年5月10日至2023年7月10日期间保定市第一中心医院收治的120例甲状腺癌患者作为研究对象,随机分为对照组和实验组(每组60例)。对照组患者接受常规护理,实验组患者接受心理护理和营养干预。比较两组患者干预前后在生活质量、依从性、满意度和认知水平方面的差异:干预后,实验组的情感功能、角色功能、认知功能、躯体功能和社会功能评分明显高于对照组,差异有统计学意义(P= 0.00);实验组的依从性为 100%,明显高于对照组的 90%,差异有统计学意义(P= 0.01)。此外,干预后实验组的 SAS 和 SDS 评分明显低于对照组,差异有统计学意义(P= 0.00):心理护理与营养干预可为接受放射性药物治疗的甲状腺癌患者带来多种益处,如有效改善患者的生活质量,提高患者对疾病的认知水平与治疗依从性,减轻患者的焦虑与抑郁情绪,提高患者对护理工作的满意度等。
{"title":"Clinical effect of psychological nursing and nutritional intervention in radiopharmaceutical therapy of patients with thyroid carcinoma.","authors":"Jing Chen, Yuanzheng Liu","doi":"10.12669/pjms.40.9.9020","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9020","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical value of psychological nursing and nutritional intervention in radiopharmaceutical therapy of patients with thyroid carcinoma.</p><p><strong>Methods: </strong>This was retrospective study. One hundred and twenty patients with thyroid carcinoma were included at Baoding No.1 Central Hospital from May 10, 2021 to July 10, 2023 to as subjects and randomly divided into the control group and the experimental group (n=60 each group). Patients in the control group were given conventional nursing, while those in the experimental group received psychological nursing and nutritional intervention. The differences in quality of life, compliance, satisfaction and cognitive level between the two groups before and after intervention were compared.</p><p><strong>Results: </strong>After intervention, the scores of emotional functions, role function, cognitive function, physical function and social function of the experimental group were significantly higher than those of the control group, with statistically significant differences (P= 0.00); The compliance of the experimental group was 100%, which was significantly higher than 90% of the control group, with a statistically significant difference (P= 0.01). Moreover, the scores of SAS and SDS in the experimental group were significantly lower than those in the control group after intervention, with a statistically significant difference (P= 0.00).</p><p><strong>Conclusion: </strong>Psychological nursing and nutritional intervention may result in a variety of benefits for patients with thyroid carcinoma receiving radiopharmaceutical therapy, such as effectively ameliorating the quality of life of patients, improving the cognitive level of patients with the disease and treatment compliance, reducing anxiety and depression, and enhancing patient satisfaction with nursing.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"1958-1963"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476149/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative efficacy of muscle energy technique and Bowen technique on hamstrings muscle tightness in chronic low back pain patients. 肌肉能量技术和鲍恩技术对慢性腰背痛患者腿筋肌肉紧绷的疗效比较。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8517
Kishwar Batool, Mariam Mehmood, Muneeb Jafar, Maham Gull

Objective: To compare the effects of the Muscle Energy Technique (MET) and the Bowen Technique on hamstring muscle tightness in chronic low back pain (CLBP) patients.

Method: A randomized clinical trial (RCT) designed study in which 62 participants were recruited through the purposive sampling technique were divided into two groups by the lottery method. Subjects who had pain for more than six months in the back and hamstring tightness were included. The duration of the study was four months from February to May 2023 conducted at Madinah Teaching Hospital Faisalabad. Subjects in Group-A were given the Bowen technique, whereas subjects in Group-B were given the MET. Numeric pain rating scale (NPRS), Oswestry disability index (ODI), and active knee extension (AKE) tests were used for measurements of outcomes.

Results: Intra-group comparison by using Friedman test revealed that both Group-A & B subject's pain were reduced (P<0.000), their tightness in back thigh muscles were significantly reduced (P<0.000) and functional activities of subjects were also improved (P<0.000). Mann Whitney test was used to determine the between group comparison. P-value ≤ 0.05 was considered as significant. Inter Group-Analysis revealed that there was no statistically significant difference between effects of Bowen technique & MET on pain, hamstring tightness and disability as both techniques improved pain, flexibility & disability.

Conclusion: This study revealed that both groups treated by MET and Bowen Technique had significantly reduced pain, improved flexibility of back thigh muscle and reduced functional disability.

目的比较肌肉能量疗法(MET)和鲍恩疗法对慢性腰背痛(CLBP)患者腿筋肌肉紧绷的影响:研究采用随机临床试验(RCT)设计,通过目的性抽样技术招募了 62 名参与者,并通过抽签法将其分为两组。研究对象包括背部疼痛超过六个月且腿筋紧绷的患者。研究为期四个月,从 2023 年 2 月至 5 月,在费萨拉巴德的麦地那教学医院进行。A 组受试者接受了鲍恩技术,而 B 组受试者则接受了 MET 技术。测量结果采用数字疼痛评分量表(NPRS)、Oswestry 残疾指数(ODI)和膝关节主动伸展(AKE)测试:结果:通过弗里德曼检验进行组内比较发现,A 组和 B 组受试者的疼痛均有所减轻(PC):本研究表明,采用 MET 和鲍温技术治疗的两组受试者的疼痛均明显减轻,大腿后侧肌肉的柔韧性得到改善,功能性残疾也有所减轻。
{"title":"Comparative efficacy of muscle energy technique and Bowen technique on hamstrings muscle tightness in chronic low back pain patients.","authors":"Kishwar Batool, Mariam Mehmood, Muneeb Jafar, Maham Gull","doi":"10.12669/pjms.40.9.8517","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8517","url":null,"abstract":"<p><strong>Objective: </strong>To compare the effects of the Muscle Energy Technique (MET) and the Bowen Technique on hamstring muscle tightness in chronic low back pain (CLBP) patients.</p><p><strong>Method: </strong>A randomized clinical trial (RCT) designed study in which 62 participants were recruited through the purposive sampling technique were divided into two groups by the lottery method. Subjects who had pain for more than six months in the back and hamstring tightness were included. The duration of the study was four months from February to May 2023 conducted at Madinah Teaching Hospital Faisalabad. Subjects in Group-A were given the Bowen technique, whereas subjects in Group-B were given the MET. Numeric pain rating scale (NPRS), Oswestry disability index (ODI), and active knee extension (AKE) tests were used for measurements of outcomes.</p><p><strong>Results: </strong>Intra-group comparison by using Friedman test revealed that both Group-A & B subject's pain were reduced (P<0.000), their tightness in back thigh muscles were significantly reduced (P<0.000) and functional activities of subjects were also improved (P<0.000). Mann Whitney test was used to determine the between group comparison. P-value ≤ 0.05 was considered as significant. Inter Group-Analysis revealed that there was no statistically significant difference between effects of Bowen technique & MET on pain, hamstring tightness and disability as both techniques improved pain, flexibility & disability.</p><p><strong>Conclusion: </strong>This study revealed that both groups treated by MET and Bowen Technique had significantly reduced pain, improved flexibility of back thigh muscle and reduced functional disability.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2080-2084"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency, risk factors, and outcome of neonatal meningitis in sepsis. 败血症新生儿脑膜炎的发病率、风险因素和预后。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8890
Saeed Ahmed, Sundus Akhtar, Aysha Sultan, Ayaz Ur Rehman

Objective: To determine the frequency, associated risk factors, and outcome of meningitis in neonates presenting with sepsis at Aga khan Tertiary Care Hospital, Karachi.

Methods: A descriptive cross-sectional study was conducted at pediatrics department of Aga Khan Tertiary University Hospital, Karachi, Pakistan from July 31, 2020, till January 30, 2021. Neonates of either gender admitted with neonatal sepsis were enrolled using non-probability consecutive sampling technique. Meningitis was diagnosed as per the findings of cerebrospinal fluid (CSF) along with the outcome in terms of death and early neurological complications such as subdural effusions and hydrocephalus.

Results: Of 209 neonates with sepsis, meningitis was observed in 59 (28.2%) neonates. A significantly lower mean weight (p-value 0.024) while significantly higher mean duration of stay (p-value <0.001) was observed in patient with meningitis. Moreover, a significantly higher proportion of meningitis was observed in neonates who had fever (p-value 0.048), vomiting (p-value 0.009), abdominal distension (p-value <0.001), and blood culture positivity (p-value <0.001). Blood culture positive Methicillin-sensitive Staphylococcus aureus (MSSA) was considerably higher among neonates with meningitis. Of 59 neonates with meningitis, mortality was observed in 2 (3.4%) neonates. Positive CSF culture was observed in 6 (2.9%) while hydrocephalus was observed in 7 (11.9%) and effusion in 6 (10.2%) neonates.

Conclusion: Neonatal meningitis is common in neonates presenting with sepsis, but mortality rate is low. Positive cultures, particularly with MSSA, further underscore the bacterial etiology in neonatal meningitis.

摘要确定卡拉奇阿迦汗三甲医院出现败血症的新生儿患脑膜炎的频率、相关风险因素和结果:从 2020 年 7 月 31 日至 2021 年 1 月 30 日,在巴基斯坦卡拉奇阿迦汗三级大学医院儿科进行了一项描述性横断面研究。采用非概率连续抽样技术,对患有新生儿败血症的男女新生儿进行了登记。脑膜炎根据脑脊液(CSF)检查结果以及死亡和早期神经系统并发症(如硬膜下积液和脑积水)的结果进行诊断:在 209 例败血症新生儿中,有 59 例(28.2%)观察到脑膜炎。平均体重明显较轻(p 值 0.024),平均住院时间明显较长(p 值 结论:新生儿脑膜炎是一种常见的新生儿疾病:新生儿脑膜炎在出现败血症的新生儿中很常见,但死亡率很低。培养阳性(尤其是 MSSA)进一步强调了新生儿脑膜炎的细菌病因。
{"title":"Frequency, risk factors, and outcome of neonatal meningitis in sepsis.","authors":"Saeed Ahmed, Sundus Akhtar, Aysha Sultan, Ayaz Ur Rehman","doi":"10.12669/pjms.40.9.8890","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8890","url":null,"abstract":"<p><strong>Objective: </strong>To determine the frequency, associated risk factors, and outcome of meningitis in neonates presenting with sepsis at Aga khan Tertiary Care Hospital, Karachi.</p><p><strong>Methods: </strong>A descriptive cross-sectional study was conducted at pediatrics department of Aga Khan Tertiary University Hospital, Karachi, Pakistan from July 31, 2020, till January 30, 2021. Neonates of either gender admitted with neonatal sepsis were enrolled using non-probability consecutive sampling technique. Meningitis was diagnosed as per the findings of cerebrospinal fluid (CSF) along with the outcome in terms of death and early neurological complications such as subdural effusions and hydrocephalus.</p><p><strong>Results: </strong>Of 209 neonates with sepsis, meningitis was observed in 59 (28.2%) neonates. A significantly lower mean weight (p-value 0.024) while significantly higher mean duration of stay (p-value <0.001) was observed in patient with meningitis. Moreover, a significantly higher proportion of meningitis was observed in neonates who had fever (p-value 0.048), vomiting (p-value 0.009), abdominal distension (p-value <0.001), and blood culture positivity (p-value <0.001). Blood culture positive Methicillin-sensitive Staphylococcus aureus (MSSA) was considerably higher among neonates with meningitis. Of 59 neonates with meningitis, mortality was observed in 2 (3.4%) neonates. Positive CSF culture was observed in 6 (2.9%) while hydrocephalus was observed in 7 (11.9%) and effusion in 6 (10.2%) neonates.</p><p><strong>Conclusion: </strong>Neonatal meningitis is common in neonates presenting with sepsis, but mortality rate is low. Positive cultures, particularly with MSSA, further underscore the bacterial etiology in neonatal meningitis.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"1964-1968"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for cardiovascular disease in women with preeclampsia and intrauterine growth restriction. 子痫前期和宫内发育受限妇女患心血管疾病的风险因素。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8184
Fehmida Memon, Samia Aijaz, Mahreen Bhatti, Naheed Sheikh

Objective: To identify the risk factors for cardiovascular disease in women with pre-eclampsia and intrauterine growth retardation.

Methods: This cross sectional study was conducted in Department of Gynecology and Obstetrics, Liaquat University Hospital, Hyderabad, from April 2022 to October 2022. Patients with history of intrauterine growth retardation or preeclampsia after 20 weeks of gestation, age more than 18 years were included in this study. Patients were assessed for cardiovascular risk factors during pregnancy.

Results: The average age and gestational age were almost equal in preeclampsia and IUGR patients, (p≤0.050). The primparous were higher in preeclampsia than IUGR, n=286 (73.5%) and n=80 (52.3%), respectively, (p=0.000). The average birth weight of IUGR was lower than preeclampsia patients, 925.19±6.35 gram and 1324.76±10.19 gram, respectively, (p=0.000). The average systolic and diastolic blood pressure of IUGR patients was less than preeclampsia patients, (p=0.000). But, the chronic hypertension was higher in preeclampsia patients n=99 (25.4%) as compare to IUGR n=13 (8.5%) patients, (p=0.000). The average cholesterol level in IUGR was 5.52±0.58(mmol/L) versus preeclampsia 5.34±1.01(mmol/L), (p=0.043). The average triglycerides was almost equal in both the groups, (p=0.924). The mean Lp(a) in preeclampsia patients was 177.15±20.15(mg/L) versus 202.94±24.83 (mg/L), (p=0.000).

Conclusion: Findings of this study help conclude that women with known history of IUGR or preeclampsia must be screened for possible cardiovascular risk factors and treated for these risk factors in order to avoid future mortality and morbidity associated with cardiovascular diseases.

目的:确定先兆子痫合并宫内发育迟缓妇女患心血管疾病的风险因素:确定患有先兆子痫和宫内发育迟缓的妇女患心血管疾病的风险因素:这项横断面研究于 2022 年 4 月至 2022 年 10 月在海得拉巴利亚卡特大学医院妇产科进行。研究对象包括妊娠 20 周后有宫内发育迟缓或子痫前期病史、年龄超过 18 岁的患者。对患者进行了孕期心血管风险因素评估:结果:子痫前期和 IUGR 患者的平均年龄和胎龄几乎相等(P≤0.050)。子痫前期患者的初产妇比例高于 IUGR 患者,分别为 286 例(73.5%)和 80 例(52.3%)(P=0.000)。IUGR 患者的平均出生体重低于子痫前期患者,分别为(925.19±6.35)克和(1324.76±10.19)克(P=0.000)。IUGR 患者的平均收缩压和舒张压均低于子痫前期患者(P=0.000)。但是,与 IUGR 患者(13 人,占 8.5%)相比,子痫前期患者(99 人,占 25.4%)的慢性高血压发病率更高(P=0.000)。IUGR 患者的平均胆固醇水平为 5.52±0.58(mmol/L),而子痫前期患者为 5.34±1.01(mmol/L),(P=0.043)。两组的甘油三酯平均值几乎相同,(P=0.924)。子痫前期患者的脂蛋白(a)平均值为(177.15±20.15)(毫克/升),而子痫中期患者的脂蛋白(a)平均值为(202.94±24.83)(毫克/升),(P=0.000):本研究的结果有助于得出结论,已知有 IUGR 或子痫前期病史的妇女必须接受可能的心血管风险因素筛查,并针对这些风险因素进行治疗,以避免未来与心血管疾病相关的死亡率和发病率。
{"title":"Risk factors for cardiovascular disease in women with preeclampsia and intrauterine growth restriction.","authors":"Fehmida Memon, Samia Aijaz, Mahreen Bhatti, Naheed Sheikh","doi":"10.12669/pjms.40.9.8184","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8184","url":null,"abstract":"<p><strong>Objective: </strong>To identify the risk factors for cardiovascular disease in women with pre-eclampsia and intrauterine growth retardation.</p><p><strong>Methods: </strong>This cross sectional study was conducted in Department of Gynecology and Obstetrics, Liaquat University Hospital, Hyderabad, from April 2022 to October 2022. Patients with history of intrauterine growth retardation or preeclampsia after 20 weeks of gestation, age more than 18 years were included in this study. Patients were assessed for cardiovascular risk factors during pregnancy.</p><p><strong>Results: </strong>The average age and gestational age were almost equal in preeclampsia and IUGR patients, (p≤0.050). The primparous were higher in preeclampsia than IUGR, n=286 (73.5%) and n=80 (52.3%), respectively, (p=0.000). The average birth weight of IUGR was lower than preeclampsia patients, 925.19±6.35 gram and 1324.76±10.19 gram, respectively, (p=0.000). The average systolic and diastolic blood pressure of IUGR patients was less than preeclampsia patients, (p=0.000). But, the chronic hypertension was higher in preeclampsia patients n=99 (25.4%) as compare to IUGR n=13 (8.5%) patients, (p=0.000). The average cholesterol level in IUGR was 5.52±0.58(mmol/L) versus preeclampsia 5.34±1.01(mmol/L), (p=0.043). The average triglycerides was almost equal in both the groups, (p=0.924). The mean Lp(a) in preeclampsia patients was 177.15±20.15(mg/L) versus 202.94±24.83 (mg/L), (p=0.000).</p><p><strong>Conclusion: </strong>Findings of this study help conclude that women with known history of IUGR or preeclampsia must be screened for possible cardiovascular risk factors and treated for these risk factors in order to avoid future mortality and morbidity associated with cardiovascular diseases.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2096-2100"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476156/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Ginger in management of nausea among patients receiving chemotherapy. 生姜在缓解化疗患者恶心方面的作用。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8739
Zamin Abbas Syed, Ammad Fahim, Mahpara Safdar, Rafia Imtiaz

Objective: Cancer patients treated with chemotherapy often face variety of side effects, with nausea and vomiting being the most frequent. Ginger (Zingiber officinale), contains natural compounds that can speed up the metabolism and increase intestinal motility. It is traditionally used to treat gastrointestinal disorders. The objective of this study was to evaluate the role of ginger in management of nausea among patients receiving chemotherapy.

Methods: This crossover interventional study was conducted to evaluate the role of ginger in management of nausea among patients receiving chemotherapy. Study was carried out at chemotherapy daycare of Shifa International Hospital Islamabad, with a sample size of 90 patients, using non-probability convenient sampling. Patients undergoing chemotherapy were given the dose of ginger (550 mg twice a day) for five consecutive days. On the next chemo cycle the same patients were given the placebo capsules of same color and weight for two times a day for five days. Patients and attendants were contacted for five days and being asked about post-chemotherapy nausea. Nausea and vomiting were measured by Rhodes scale.

Results: Results showed that Rhodes score of patients taking Ginger capsules was significantly lower than those taking placebo (p-value < 0.05) in all the five days.

Conclusion: Ginger significantly managed the nausea among patients receiving chemotherapy. Its natural antiemetic properties provide a convenient and safe way to reduce the post-chemotherapy nausea and vomiting.

目的接受化疗的癌症患者通常会面临各种副作用,其中最常见的是恶心和呕吐。生姜(Zingiber officinale)含有天然化合物,可加快新陈代谢,增加肠道蠕动。生姜传统上用于治疗胃肠道疾病。本研究旨在评估生姜在缓解化疗患者恶心方面的作用:这项交叉干预研究旨在评估生姜在缓解化疗患者恶心症状方面的作用。研究在伊斯兰堡希法国际医院化疗日间护理中心进行,样本量为 90 名患者,采用非概率方便抽样法。接受化疗的患者连续五天服用生姜(550 毫克,一天两次)。在下一个化疗周期,同样的患者服用相同颜色和重量的安慰剂胶囊,每天两次,连续服用五天。连续五天与患者和护理人员联系,询问化疗后的恶心情况。恶心和呕吐用罗兹量表进行测量:结果表明,服用生姜胶囊的患者在所有五天中的罗德评分均明显低于服用安慰剂的患者(P 值小于 0.05):结论:生姜能明显缓解化疗患者的恶心症状。生姜的天然止吐特性为减轻化疗后的恶心和呕吐提供了一种方便、安全的方法。
{"title":"Role of Ginger in management of nausea among patients receiving chemotherapy.","authors":"Zamin Abbas Syed, Ammad Fahim, Mahpara Safdar, Rafia Imtiaz","doi":"10.12669/pjms.40.9.8739","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8739","url":null,"abstract":"<p><strong>Objective: </strong>Cancer patients treated with chemotherapy often face variety of side effects, with nausea and vomiting being the most frequent. Ginger (<i>Zingiber officinale</i>), contains natural compounds that can speed up the metabolism and increase intestinal motility. It is traditionally used to treat gastrointestinal disorders. The objective of this study was to evaluate the role of ginger in management of nausea among patients receiving chemotherapy.</p><p><strong>Methods: </strong>This crossover interventional study was conducted to evaluate the role of ginger in management of nausea among patients receiving chemotherapy. Study was carried out at chemotherapy daycare of Shifa International Hospital Islamabad, with a sample size of 90 patients, using non-probability convenient sampling. Patients undergoing chemotherapy were given the dose of ginger (550 mg twice a day) for five consecutive days. On the next chemo cycle the same patients were given the placebo capsules of same color and weight for two times a day for five days. Patients and attendants were contacted for five days and being asked about post-chemotherapy nausea. Nausea and vomiting were measured by Rhodes scale.</p><p><strong>Results: </strong>Results showed that Rhodes score of patients taking Ginger capsules was significantly lower than those taking placebo (p-value < 0.05) in all the five days.</p><p><strong>Conclusion: </strong>Ginger significantly managed the nausea among patients receiving chemotherapy. Its natural antiemetic properties provide a convenient and safe way to reduce the post-chemotherapy nausea and vomiting.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2036-2040"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical application of 3D-printed fusion cage implantation in treating cervical spondylotic myelopathy. 三维打印融合笼植入治疗颈椎病的临床应用。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9125
Yue Ma, De-Bao Zhang, Fan Li, Yang Song

Objective: To investigate the clinical efficacy of 3D-printed fusion cage implantation in treating cervical spondylotic myelopathy.

Methods: A retrospective analysis was performed on 52 patients with single-segment cervical spondylotic myelopathy who received anterior cervical discectomy and fusion in Affiliated Hospital of Beihua University from July 2019 to July 2022. They were divided into the 3D group and the control group. Afterward, the perioperative indicators were compared between the two groups. Meanwhile, the Japanese Orthopaedic Association (JOA) scores, Visual analogue scale (VAS) and neck disability index (NDI) were recorded pre-operation and one-year post-operation. Evaluate the fusion rate of two group of intervertebral fusion cages.

Results: The JOA score and NDI of the two groups of patients were significantly improved compared to pre-operation(P<0.05), and the JOA score, JOA score improvement rate, and NDI of the 3D group were better than the control group (P<0.05), the VAS scores were significantly improved compared to pre-operation(P<0.05), but there was no statistically significant difference between the groups (p >0.05). The intervertebral height, angle, and cervical Cobb angle of the two groups of patients were significantly improved compared to pre-operation (P<0.05), and the improvement of intervertebral height, angle, and cervical Cobb angle in the 3D group was better than the control group(P<0.05).

Conclusion: The clinical efficacy of 3D printed intervertebral fusion cage placement in the treatment of cervical spondylotic myelopathy may be reliable, and it would be better than traditional intervertebral fusion cages in maintaining the height, angle, cervical Cobb angle, and fusion rate of the intervertebral space.

目的研究3D打印融合笼植入治疗颈椎病的临床疗效:对2019年7月至2022年7月在北华大学附属医院接受前路颈椎椎间盘切除融合术的52例单节段颈椎病患者进行回顾性分析。他们被分为三维组和对照组。之后,对两组围手术期指标进行比较。同时,记录术前和术后一年的日本骨科协会(JOA)评分、视觉模拟量表(VAS)和颈部残疾指数(NDI)。评估两组椎间融合器的融合率:两组患者的 JOA 评分和 NDI 与术前相比均有明显改善(P0.05)。两组患者的椎间高度、角度和颈椎 Cobb 角与手术前相比均有明显改善(P0.05):3D打印椎间融合器笼置入治疗颈椎病的临床疗效可能是可靠的,在保持椎间隙高度、角度、颈椎Cobb角和融合率方面优于传统的椎间融合器笼。
{"title":"Clinical application of 3D-printed fusion cage implantation in treating cervical spondylotic myelopathy.","authors":"Yue Ma, De-Bao Zhang, Fan Li, Yang Song","doi":"10.12669/pjms.40.9.9125","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9125","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical efficacy of 3D-printed fusion cage implantation in treating cervical spondylotic myelopathy.</p><p><strong>Methods: </strong>A retrospective analysis was performed on 52 patients with single-segment cervical spondylotic myelopathy who received anterior cervical discectomy and fusion in Affiliated Hospital of Beihua University from July 2019 to July 2022. They were divided into the 3D group and the control group. Afterward, the perioperative indicators were compared between the two groups. Meanwhile, the Japanese Orthopaedic Association (JOA) scores, Visual analogue scale (VAS) and neck disability index (NDI) were recorded pre-operation and one-year post-operation. Evaluate the fusion rate of two group of intervertebral fusion cages.</p><p><strong>Results: </strong>The JOA score and NDI of the two groups of patients were significantly improved compared to pre-operation(P<0.05), and the JOA score, JOA score improvement rate, and NDI of the 3D group were better than the control group (P<0.05), the VAS scores were significantly improved compared to pre-operation(P<0.05), but there was no statistically significant difference between the groups (p >0.05). The intervertebral height, angle, and cervical Cobb angle of the two groups of patients were significantly improved compared to pre-operation (P<0.05), and the improvement of intervertebral height, angle, and cervical Cobb angle in the 3D group was better than the control group(P<0.05).</p><p><strong>Conclusion: </strong>The clinical efficacy of 3D printed intervertebral fusion cage placement in the treatment of cervical spondylotic myelopathy may be reliable, and it would be better than traditional intervertebral fusion cages in maintaining the height, angle, cervical Cobb angle, and fusion rate of the intervertebral space.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2085-2089"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research on influenza epidemic and clinical characteristics based on influenza research database. 基于流感研究数据库的流感流行病和临床特征研究。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8470
Guowei Li, Rongyuan Yang, Rui Chen, Yuejia Zhong, Manhua Huang

Objective: To compare the epidemic trends of different types of influenza viruses and the clinical characteristics of patients, so as to provide reference for influenza prevention and control.

Methods: This was descriptive research. The human monitoring data collected from the Influenza Research Database (IRD) from 2006 to 2016 were used to descriptively analyze the distribution of influenza viruses in terms of time, geography, gender and age. The positive samples were divided into three groups based on the type of pathogen (H1N1 influenza A viruses, H3N2 influenza A viruses, and influenza B viruses). Compared and analyzed the distribution and clinical characteristics among groups.

Results: There were statistically significant differences in the positive rates among different countries (p< 0.001). The proportion of positive samples gradually decreased with age. The proportion of oseltamivir resistance was significantly higher in H1N1-positive patients compared with that in H3N2-positive patients (p< 0.001). Significant differences were observed in the vaccination status among H1N1, H3N2 and influenza B viruses (p< 0.001). Cough was common in all cases with H1N1, H3N2 and influenza B infections, while cough, fever and running nose occurred more frequently in influenza B-positive cases than those of H1N1-positive and H3N2-positive cases (p< 0.001).

Conclusion: People aged 0-18 years are the major susceptible population to influenza, and H1N1 influenza viruses are the main pathogens of infection in this population, with major clinical manifestations of fever, cough and headache. The findings in this study highlight the necessity to strengthen the protection for this age group in clinical practice.

目的:比较不同类型流感病毒的流行趋势和患者的临床特征,为预防和控制流感提供参考:比较不同类型流感病毒的流行趋势和患者的临床特征,为流感防控提供参考:本研究为描述性研究。利用从流感研究数据库(IRD)中收集的 2006 年至 2016 年人类监测数据,从时间、地域、性别和年龄等方面对流感病毒的分布进行描述性分析。根据病原体类型(甲型 H1N1 流感病毒、甲型 H3N2 流感病毒和乙型流感病毒)将阳性样本分为三组。比较并分析了各组间的分布和临床特征:结果:不同国家的阳性率差异有统计学意义(P 0.001)。随着年龄的增长,阳性样本的比例逐渐下降。与 H3N2 阳性患者相比,H1N1 阳性患者对奥司他韦耐药的比例明显更高(P 0.001)。甲型 H1N1、甲型 H3N2 和乙型流感病毒的疫苗接种情况存在显著差异(P 0.001)。所有感染 H1N1、H3N2 和乙型流感的病例都有咳嗽,而乙型流感阳性病例的咳嗽、发烧和流鼻涕发生率高于 H1N1 阳性和 H3N2 阳性病例(P 0.001):0-18岁人群是流感的主要易感人群,甲型H1N1流感病毒是这一人群感染的主要病原体,主要临床表现为发热、咳嗽和头痛。本研究的结果凸显了在临床实践中加强对这一年龄段人群防护的必要性。
{"title":"Research on influenza epidemic and clinical characteristics based on influenza research database.","authors":"Guowei Li, Rongyuan Yang, Rui Chen, Yuejia Zhong, Manhua Huang","doi":"10.12669/pjms.40.9.8470","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8470","url":null,"abstract":"<p><strong>Objective: </strong>To compare the epidemic trends of different types of influenza viruses and the clinical characteristics of patients, so as to provide reference for influenza prevention and control.</p><p><strong>Methods: </strong>This was descriptive research. The human monitoring data collected from the Influenza Research Database (IRD) from 2006 to 2016 were used to descriptively analyze the distribution of influenza viruses in terms of time, geography, gender and age. The positive samples were divided into three groups based on the type of pathogen (H1N1 influenza A viruses, H3N2 influenza A viruses, and influenza B viruses). Compared and analyzed the distribution and clinical characteristics among groups.</p><p><strong>Results: </strong>There were statistically significant differences in the positive rates among different countries (<i>p<</i> 0.001). The proportion of positive samples gradually decreased with age. The proportion of oseltamivir resistance was significantly higher in H1N1-positive patients compared with that in H3N2-positive patients (<i>p<</i> 0.001). Significant differences were observed in the vaccination status among H1N1, H3N2 and influenza B viruses (<i>p<</i> 0.001). Cough was common in all cases with H1N1, H3N2 and influenza B infections, while cough, fever and running nose occurred more frequently in influenza B-positive cases than those of H1N1-positive and H3N2-positive cases (<i>p<</i> 0.001).</p><p><strong>Conclusion: </strong>People aged 0-18 years are the major susceptible population to influenza, and H1N1 influenza viruses are the main pathogens of infection in this population, with major clinical manifestations of fever, cough and headache. The findings in this study highlight the necessity to strengthen the protection for this age group in clinical practice.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2056-2062"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476142/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The safety and efficacy of through-and-through wire technique for ureteral Double-J stent placement. 输尿管双 J 型支架置入的穿透式导线技术的安全性和有效性。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9424
Cheng Shi Chen, Chu Hui Zeng, Ji Hoon Shin, Suyoung Park, Hai Liang Li, Fang Kun Li

Objective: To evaluate the efficacy and safety of the through-and-through wire (TTW) technique for antegrade ureteral Double-J stent placement after failure of either antegrade or retrograde ureteral stent placement.

Method: This retrospective study analyzed the medical records of consecutive patients who underwent Double-J stent placement with the TTW technique at Asan Medical Center and Gil Medical Center between January 2016 and February 2023. Patient histories, reasons for employing the TTW technique, TTW pathways, and complications were reviewed. Eight patients were included in the study. The reasons for using the TTW technique were failure to advance a larger-diameter catheter, balloon catheter, or Double-J stent passing over the guidewire beyond the stricture (6/8, 75.0%); failure to negotiate the stricture with a guidewire (1/8, 12.5%); and guidewire passing through a ureteropelvic junction defect (1/8, 12.5%).

Results: TTW was applied either between a percutaneous nephrostomy (PCN) and the urethral orifice (n=4), between a PCN and an ileostomy pouch (n=3), or between a left and right PCN (n = 1). Urologic assistance was required for retrograde ureteral cannulation in one male patient (12.5%). Subsequently, balloon dilation and/or Double-J stent placement were performed in all eight patients, resulting in 100% technical success. No major or minor complications occurred.

Conclusions: The TTW technique was safe and effective in the undertaking of PCN and antegrade Double-J stent placement in patients for whom either antegrade or retrograde access had failed.

目的评估在输尿管前行或逆行支架置入失败后,采用贯通线(TTW)技术进行输尿管前行双J支架置入的有效性和安全性:这项回顾性研究分析了2016年1月至2023年2月期间在牙山医疗中心和吉尔医疗中心接受TTW技术Double-J支架置入术的连续患者的病历。研究回顾了患者病史、采用 TTW 技术的原因、TTW 路径和并发症。八名患者被纳入研究。使用TTW技术的原因包括:未能将大直径导管、球囊导管或Double-J支架穿过导丝推进到狭窄处以外(6/8,75.0%);未能用导丝与狭窄处进行协商(1/8,12.5%);导丝穿过输尿管盆腔交界处缺损(1/8,12.5%):结果:TTW应用于经皮肾造口术(PCN)和尿道口之间(4例)、PCN和回肠造口袋之间(3例)或左右PCN之间(1例)。一名男性患者(12.5%)需要泌尿科协助进行逆行输尿管插管。随后,对所有八名患者进行了球囊扩张和/或双J支架置入,技术成功率为100%。无重大或轻微并发症发生:结论:TTW技术在对前向或逆行入路失败的患者进行PCN和前向Double-J支架置入术时安全有效。
{"title":"The safety and efficacy of through-and-through wire technique for ureteral Double-J stent placement.","authors":"Cheng Shi Chen, Chu Hui Zeng, Ji Hoon Shin, Suyoung Park, Hai Liang Li, Fang Kun Li","doi":"10.12669/pjms.40.9.9424","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9424","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of the through-and-through wire (TTW) technique for antegrade ureteral Double-J stent placement after failure of either antegrade or retrograde ureteral stent placement.</p><p><strong>Method: </strong>This retrospective study analyzed the medical records of consecutive patients who underwent Double-J stent placement with the TTW technique at Asan Medical Center and Gil Medical Center between January 2016 and February 2023. Patient histories, reasons for employing the TTW technique, TTW pathways, and complications were reviewed. Eight patients were included in the study. The reasons for using the TTW technique were failure to advance a larger-diameter catheter, balloon catheter, or Double-J stent passing over the guidewire beyond the stricture (6/8, 75.0%); failure to negotiate the stricture with a guidewire (1/8, 12.5%); and guidewire passing through a ureteropelvic junction defect (1/8, 12.5%).</p><p><strong>Results: </strong>TTW was applied either between a percutaneous nephrostomy (PCN) and the urethral orifice (n=4), between a PCN and an ileostomy pouch (n=3), or between a left and right PCN (n = 1). Urologic assistance was required for retrograde ureteral cannulation in one male patient (12.5%). Subsequently, balloon dilation and/or Double-J stent placement were performed in all eight patients, resulting in 100% technical success. No major or minor complications occurred.</p><p><strong>Conclusions: </strong>The TTW technique was safe and effective in the undertaking of PCN and antegrade Double-J stent placement in patients for whom either antegrade or retrograde access had failed.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"1907-1913"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy and safety of targeted therapy, immunotherapy combined with chemotherapy for treating patients with advanced gastric cancer. 靶向疗法、免疫疗法联合化疗治疗晚期胃癌患者的临床疗效和安全性。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9049
Dongyan Yang, Zhilong Gao, Xuezhu Yang, Liguo Gao

Objective: Exploring the clinical efficacy and safety of targeted therapy, immunotherapy combined with chemotherapy in the treatment of advanced gastric cancer.

Methods: A retrospective analysis was performed on the medical records of 134 patients with advanced gastric cancer who visited Renmin Hospital, Hubei University of Medicine from January 2019 to December 2022. According to therapeutic regimens, enrolled patients were divided into the control group and the study group. Patients in the control group received chemotherapy intervention, while those in the study group were provided with a combined intervention of apatinib, PD-1 inhibitor and chemotherapy. We analyze the tumor control effect and incidence of adverse reactions in two groups of patients.

Results: The disease control rate (DCR) of patients in the study group and the control group was 72.06% and 42.42%, with an overall response rate (ORR) of 8.82% and 4.55%, The differences are statistically significant(P<0.05). By the end of follow-up, the median progression-free survival (mPFS) and the median overall survival (mOS) of the control group patients were 3.0±0.266 and 5.0±0.224 months respectively; while the mPFS and mOS of the study group were 5.0±0.261 and 7.0±0.172 months respectively, the differences are statistically significant (P<0.05). However, there was no significant difference in adverse reactions between the two groups (P>0.05).

Conclusion: The therapeutic regimen of apatinib, a PD-1 inhibitor combined with chemotherapy exhibits relatively high clinical efficacy and safety for the treatment of patients with advanced gastric cancer. It can be considered as an interventional option for this type of patient.

目的:探讨靶向治疗、免疫治疗联合化疗治疗晚期胃癌的临床疗效和安全性:探讨靶向治疗、免疫治疗联合化疗治疗晚期胃癌的临床疗效和安全性:对2019年1月至2022年12月在湖北医药学院附属人民医院就诊的134例晚期胃癌患者的病历资料进行回顾性分析。根据治疗方案,入组患者被分为对照组和研究组。对照组患者接受化疗干预,研究组患者接受阿帕替尼、PD-1抑制剂和化疗联合干预。我们分析了两组患者的肿瘤控制效果和不良反应发生率:研究组和对照组患者的疾病控制率(DCR)分别为72.06%和42.42%,总反应率(ORR)分别为8.82%和4.55%,差异有统计学意义(P0.05):PD-1抑制剂阿帕替尼联合化疗方案治疗晚期胃癌患者具有较高的临床疗效和安全性。可以考虑将其作为这类患者的介入治疗方案。
{"title":"Clinical efficacy and safety of targeted therapy, immunotherapy combined with chemotherapy for treating patients with advanced gastric cancer.","authors":"Dongyan Yang, Zhilong Gao, Xuezhu Yang, Liguo Gao","doi":"10.12669/pjms.40.9.9049","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9049","url":null,"abstract":"<p><strong>Objective: </strong>Exploring the clinical efficacy and safety of targeted therapy, immunotherapy combined with chemotherapy in the treatment of advanced gastric cancer.</p><p><strong>Methods: </strong>A retrospective analysis was performed on the medical records of 134 patients with advanced gastric cancer who visited Renmin Hospital, Hubei University of Medicine from January 2019 to December 2022. According to therapeutic regimens, enrolled patients were divided into the control group and the study group. Patients in the control group received chemotherapy intervention, while those in the study group were provided with a combined intervention of apatinib, PD-1 inhibitor and chemotherapy. We analyze the tumor control effect and incidence of adverse reactions in two groups of patients.</p><p><strong>Results: </strong>The disease control rate (DCR) of patients in the study group and the control group was 72.06% and 42.42%, with an overall response rate (ORR) of 8.82% and 4.55%, The differences are statistically significant(P<0.05). By the end of follow-up, the median progression-free survival (mPFS) and the median overall survival (mOS) of the control group patients were 3.0±0.266 and 5.0±0.224 months respectively; while the mPFS and mOS of the study group were 5.0±0.261 and 7.0±0.172 months respectively, the differences are statistically significant (P<0.05). However, there was no significant difference in adverse reactions between the two groups (P>0.05).</p><p><strong>Conclusion: </strong>The therapeutic regimen of apatinib, a PD-1 inhibitor combined with chemotherapy exhibits relatively high clinical efficacy and safety for the treatment of patients with advanced gastric cancer. It can be considered as an interventional option for this type of patient.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2101-2106"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pakistan Journal of Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1